Study Links Preservative to Colon Cancer Pathways

Computational and cell-model research suggests methylparaben may affect a monoamine oxidase gene implicated in colorectal cancer biology.

Updated on Nov. 10, 2026 in Cancer

Bold vector editorial illustration of a clear glass flask with amber liquid and suspended cell-like spheres beneath drifting molecular bonds, in teal, coral, and cream.
Researchers report a computational and cell-model link between the common preservative methylparaben and a gene tied to colorectal cancer biology, though the findings remain preliminary and do not show it causes cancer. AI Illustration. Upload story photo >

A study published November 10, 2026 combined network toxicology, transcriptomic analysis, and machine learning to examine methylparaben, a common preservative in personal care products, foods, and pharmaceuticals. Its findings point to a possible molecular link between the preservative and colorectal cancer-related signaling, though the relationships remain hypothetical.

Why it matters

Methylparaben is widely used in everyday products, so understanding its possible biological effects on colon cells is of broad public interest. The results are preliminary and computational in part, and they do not establish that the preservative causes or promotes cancer.

The evidence combines bulk transcriptomic analysis of 685 samples from four GEO datasets with a 100 ns molecular dynamics simulation, against a comparator of colon epithelial cells in which MAOB expression was relatively higher than in inferred malignant cells. Causal roles of these molecular relationships remain unresolved and require direct experimental validation.

The details

Researchers predicted methylparaben targets and overlapped them with colorectal cancer transcriptomic alterations, identifying 52 candidate genes and six feature genes, including monoamine oxidase B (MAOB). In NCM460 normal colon cells, methylparaben exposure reduced colony formation, wound closure, and invasion, while RKO colorectal cancer cells showed opposite responses under the tested in vitro conditions.

Timeline

  1. November 10, 2026: The study was published early as accepted peer-reviewed research.

Health Landscape

The study draws on public transcriptomic datasets deposited in the Gene Expression Omnibus to build its colorectal cancer analysis, extending that resource toward questions about everyday chemical exposure. It is a computational and cell-based step rather than a clinical finding, and it sits within ongoing efforts to connect environmental chemical exposures with cancer-related gene networks.

The findings do not change current recommendations about methylparaben use or cancer screening. Readers concerned about preservative exposure should rely on guidance from regulators and clinicians until controlled studies confirm or refute these proposed molecular links.

The takeaway

Computational findings like these generate hypotheses rather than conclusions, and they typically require laboratory and clinical testing before any health implications can be drawn. Readers should treat headlines about everyday chemicals with caution until independent experiments replicate the results.

Further reading

Explore more on Cancer research and risk factors.

Source note: This article includes information reported by Nature.